Yahoo Finance6d
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
Mena FN5d
Trinity Biotech Reports Landmark First-Day Accuracy Gains In CGM Pre-Pivotal Trial
(MENAFN- GlobeNewsWire - Nasdaq) Trinity Biotech's patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029 DUBLIN, Feb. 06, 2025 (GLOBE ...
Business Insider6d
Trinity Biotech reports findings from latest pre-pivotal trial on CGM system
The latest analysis confirms that first-day accuracy – a critical performance metric for CGM users – shows an approximately 35% improvement in Mean Absolute Relative Difference and a more than ...
Business Insider6d
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more ...
Yahoo Finance6d
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...
Finanznachrichten6d
Trinity Biotech plc: Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more ...
Nasdaq6d
Trinity Biotech Reveals New Findings From Pre-Pivotal Trial Of Next-Gen CGM
These advancements address a key issue in the CGM market—first-day sensor accuracy, which has historically fluctuated due to body responses. The trial, involving 30 diabetic participants ...
Taiwan News5d
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029 DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc ...
The Independent6d
One in five UK adults living with diabetes or pre-diabetes as diagnoses reach all-time high
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...
Diabetes.co.uk4d
Type 1 diabetes-related problems predicted by continuous glucose monitors
How CGM sensors work and how to look after them Use of Continuous Glucose Monitors by People With and Without Diabetes New continuous glucose monitoring system to transform diabetes care First author ...
ITV6d
One in five UK adults ‘living with diabetes or prediabetes’, data shows
One in five adults in the UK is thought to be living with diabetes or prediabetes, which causes higher than normal blood sugars and carries a greater risk of developing the condition, according to ...
Diabetes.co.uk6d
1 in 5 UK adults living with either diabetes or prediabetes
One in five adults is now living with either diabetes or prediabetes. The latest data reveals a concerning rise in cases, highlighting the urgent need for better prevention, earlier diagnosis and ...